Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
China Journal of Chinese Materia Medica ; (24): 301-305, 2022.
Artigo em Chinês | WPRIM | ID: wpr-927971

RESUMO

Ginkgo biloba Extract( GBE50) Dispersible Tablets is a new standardized prescription,which is widely used in the treatment of ischemic cardiovascular and cerebrovascular diseases. However,there are still many problems in its clinical application.Rational and safe use of GBE50 Dispersible Tablets is pivotal to the medication safety and clinical prognosis of patients. This consensus has been jointly formulated by clinical experts of traditional Chinese medicine and western medicine in cardiovascular and cerebrovascular diseases and followed the Manual for the Clinical Experts Consensus of Chinese Patent Medicine published by the China Association of Chinese Medicine. The present study identified clinical problems based on clinical investigation,searched the research papers according to PICO clinical problems,carried out evidence evaluation,classification,and recommendation by GRADE system,and reached the expert consensus with nominal group technique. The consensus combines evidence with expert experience. Sufficient evidence of clinical problems corresponds to " recommendations",while insufficient evidence to " suggestions". Safety issues of GBE50 Dispersible Tablets,such as indications,usage and dosage,and medication for special populations,are defined to improve clinical efficacy,promote rational medication,and reduce drug risks. This consensus needs to be revised based on emerging clinical issues and evidencebased updates in practical applications in the future.


Assuntos
Humanos , Transtornos Cerebrovasculares/tratamento farmacológico , Consenso , Medicamentos de Ervas Chinesas/uso terapêutico , Medicina Tradicional Chinesa , Comprimidos
2.
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 153-155, 2009.
Artigo em Chinês | WPRIM | ID: wpr-337528

RESUMO

<p><b>OBJECTIVE</b>To observe changes in activity and proliferation of cultured Schwann cells under the high glucose condition and effect of allyl glycoside extracted from Herba Rhodiolae (AG) on these changes for exploring the possible mechanism of diabetic peripheral nerve injury and the pharmacologic action of AG on them.</p><p><b>METHODS</b>Adopting refined Brokes method, Schwann cells were isolated from the sciatic nerve tissue of newborn Wistar rats and purified. Their activity and proliferative capability were determined using XTT method and 3H-TdR incorporative method respectively.</p><p><b>RESULTS</b>High glucose showed marked inhibitory effect on both activity and proliferative capability of Schwann cells, and the inhibition could be markedly improved by AG.</p><p><b>CONCLUSION</b>Diabetic peripheral nerve injury is possibly related to inhibitory effect of high glucose on activity and proliferative capability of Schwann cells. Effect of AG in improving these inhibitory changes provides the experiment basis for clinical use of traditional Chinese medicine, Herba Rhodiolae.</p>


Assuntos
Animais , Masculino , Ratos , Animais Recém-Nascidos , Proliferação de Células , Células Cultivadas , Neuropatias Diabéticas , Medicamentos de Ervas Chinesas , Farmacologia , Glucose , Farmacologia , Glicosídeos , Farmacologia , Plantas Medicinais , Química , Ratos Wistar , Células de Schwann , Biologia Celular , Nervo Isquiático , Biologia Celular
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA